Canada markets open in 6 hours 59 minutes

Summit Therapeutics Inc. (SMMT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.7000+0.7700 (+19.59%)
At close: 04:00PM EDT
4.6500 -0.05 (-1.06%)
After hours: 07:22PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.29B
Enterprise Value 3.25B
Trailing P/E 12.34
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)74.47
Enterprise Value/Revenue 6.43k
Enterprise Value/EBITDA -5.44

Trading Information

Stock Price History

Beta (5Y Monthly) -1.20
52-Week Change 3167.05%
S&P500 52-Week Change 323.57%
52 Week High 35.2200
52 Week Low 31.5000
50-Day Moving Average 34.0493
200-Day Moving Average 32.7881

Share Statistics

Avg Vol (3 month) 32.21M
Avg Vol (10 day) 31.89M
Shares Outstanding 5701.98M
Implied Shares Outstanding 6701.7M
Float 883.17M
% Held by Insiders 188.12%
% Held by Institutions 14.89%
Shares Short (Apr 15, 2024) 422.9M
Short Ratio (Apr 15, 2024) 48.66
Short % of Float (Apr 15, 2024) 427.50%
Short % of Shares Outstanding (Apr 15, 2024) 43.26%
Shares Short (prior month Mar 15, 2024) 416.96M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-12.79%
Return on Equity (ttm)-601.85%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -88.54M
Net Income Avi to Common (ttm)-614.93M
Diluted EPS (ttm)-0.9900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)186.24M
Total Cash Per Share (mrq)0.26
Total Debt (mrq)106.1M
Total Debt/Equity (mrq)136.56%
Current Ratio (mrq)9.30
Book Value Per Share (mrq)0.11

Cash Flow Statement

Operating Cash Flow (ttm)-76.76M
Levered Free Cash Flow (ttm)-219.82M